Patents by Inventor Cecilia Marianne Oderup

Cecilia Marianne Oderup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-LYMPHOTOXIN BETA RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230365701
    Abstract: Antibodies that specifically bind to LTBR are provided. Also provided are uses of these antibodies, and related compositions and methods.
    Type: Application
    Filed: May 10, 2023
    Publication date: November 16, 2023
    Applicant: Pfizer Inc.
    Inventors: James Reasoner APGAR, Bas Joannes Gertrudis BAATEN, Aruna BITRA, Javier Fernando CHAPARRO RIGGERS, Giuseppe DI CARO, Pawel Kamil DOMINIK, Zachary John MABEN, Lidia MOSYAK, Andrew Ross NAGER, Cecilia Marianne ODERUP, Edward Derrick PASCUA, Shahram SALEK-ARDAKANI, Dirk Michael ZAJONC
  • COMBINATION THERAPIES USING CDK INHIBITORS
    Publication number: 20230053328
    Abstract: This invention relates to a method for treating cancer by administering a CDK4/6 inhibitor or CDK2/4/6 inhibitor in combination with a 4-1BB agonist and/or an OX40 agonist to a subject in need thereof.
    Type: Application
    Filed: May 21, 2020
    Publication date: February 16, 2023
    Applicant: Pfizer Inc.
    Inventors: Stephen George Dann, Cecilia Marianne Oderup, Shahram Salek-Ardakani
  • Combination Treatments Of Cancer Comprising A TLR Agonist
    Publication number: 20220370606
    Abstract: The present disclosure describes combination therapies and uses thereof for the treatment of cancer. The combinations therapies include at least a first therapeutic agent and a second therapeutic agent.
    Type: Application
    Filed: December 18, 2019
    Publication date: November 24, 2022
    Applicant: Pfizer Inc.
    Inventors: Shih-Hsun CHEN, Luca MICCI, Cecilia Marianne ODERUP, Shahram SALEK-ARDAKANI, Jie WEI
  • COMBINATION THERAPIES USING CDK INHIBITORS
    Publication number: 20220241412
    Abstract: This invention relates to a method for treating cancer by administering a CDK4/6 or a CDK2/4/6 inhibitor in combination with a PD-1 axis binding antagonist, and optionally an OX40 agonist and/or a 4-1BB agonist to a subject in need thereof.
    Type: Application
    Filed: May 20, 2020
    Publication date: August 4, 2022
    Inventors: Stephen George Dann, Cecilia Marianne Oderup, Shahram Salek-Ardakani
  • COMBINATION THERAPIES USING CDK INHIBITORS
    Publication number: 20220235141
    Abstract: This invention relates to a method for treating cancer by administering a CDK4/6 inhibitor or CDK2/4/6 inhibitor in combination with a 4-1BB agonist and/or an OX40 agonist to a subject in need thereof.
    Type: Application
    Filed: May 21, 2020
    Publication date: July 28, 2022
    Applicant: Pfizer Inc.
    Inventors: Stephen George Dann, Cecilia Marianne Oderup, Shahram Salek-Ardakani